- The procedure gold mine ASCs are sitting on
- Google, J&J Foundation invest $10M in rural healthcare AI training
- AI regrets? Health systems learn lessons from the early boom
- Amazon Health adds strategic growth leader
- Memorial Health set to open $27.5M outpatient medical center
- ADA updates CDT codes for 2027: 5 notes
- Is supply chain still a cost center? Leaders weigh in
- Where the ASC industry is getting the anesthesia conversation wrong
- ChristianaCare CEO to retire; successor named
- The payer policies driving the most friction in musculoskeletal care
- Ohio system opens $27.5M outpatient center
- Cleveland Clinic expands pediatric treatments for esophageal disorder
- 4 states disciplining dentists
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Mount Sinai, OSU Wexner win radiation department award
- Physicians’ broken wRVU model
- Where 2 interstate dental compacts stand in 2026
- Viewpoint: Safeguarding care in rural Missouri demands a new approach
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- The unsolved problem plaguing ASCs
- 43 states have mental health insurance disparities: 4 trends
- 43 states have mental health insurance disparities: 4 trends
- R1 RCM launches AI tools for AR recovery, denials
- R1 RCM launches AI tools for AR recovery, denials
- The compensation divide between self-employed, employed physicians is shrinking
- CFOs as strategists: How finance leaders are rewriting their role
- The new playbook for clinician well-being
- Listen to the Latest ‘KFF Health News Minute’
- The dual payoff of dental AI
- Estados cambian leyes para evitar que hijos de inmigrantes detenidos entren al sistema de cuidado temporal
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- CPIhealth acquires Indiana spine ASC
- Small Talk? It May Be Better Than You Think
- 5 anesthesia staffing models ASCs are adopting in 2026
- Ohio long-term acute care hospital to close, lay off 116
- Mount Sinai, Anthem reach 3-year agreement
- Days cash on hand at 50 health systems
- Cómo hacer que un plan de salud con deducible alto funcione para tí
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Marriage's Hidden Benefit? A Lower Risk Of Cancer
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Para muchos pacientes que salen de terapia intensiva, la lucha apenas comienza
- Does Your Child Have Nightmares? Here's One Solution
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Los estados se enfrentan a otro reto con las nuevas reglas laborales de Medicaid: la falta de personal
- New Orleans Takes Steps To Assess and Clean Lead in Playgrounds After Investigation
- States Change Custody Laws To Keep Children of Detained Immigrants Out of Foster Care
- WebMD Ignite rolls out program to help providers get Rural Health Transformation efforts off the ground
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- Maine enacts law expanding scope of practice for independent dental hygienists
- NewYork-Presbyterian to enact behavioral health reforms, pay $500K in wake of investigation
- NYU awarded $5.5M to expand oral health center
- Smile Partners USA partners with Illinois dentist
- Mississippi hospital could close June 15
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- California behavioral health hospital to add inpatient beds
- Freedom of Associations
- When “Fail First” Fails Patients: Why Step Therapy Exception Requests Matter More Than Ever
- Why corporate dentistry gets a bad rap
- ECU dental school expands dental hygienist pipeline with new degree
- 8 dentists stepping into new leadership roles
- Pioneering exposure therapy psychologist dies
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- New Mental Health Parity Index highlights where disparities persist
- How University Hospitals swung to $190M in operating income after years of losses
- CMS taps 150 digital health companies, providers for ACCESS Model
- 10 providers seeking RCM talent
- Optum allows mental health NPs to offer transcranial magnetic stimulation
- National behavioral health association taps president, CEO
- Healthcare spending varies widely between metropolitan areas: HCCI
- CMS’ proposed pay bump inadequate, hospitals say
- Wavelet Medical, Aegis Ventures partner on first AI non-invasive fetal EEG monitoring platform
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- New Rules May Allow Broader Picks for CDC Vaccine Panel
- Second Meningitis Vaccine Doses Offered After U.K. Outbreak
- Crackdown on Vapes Falling Short, Report Finds
- Jasmine Rice Recalled Nationwide Over Possible Contamination
- AI speeds up prior auth, coding while driving higher costs for health systems: PHTI report
- ‘The next opioid epidemic’: Gambling legalization outpaces public health response to addiction
- Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare
- Fighting High Blood Pressure? Having A Team On Your Side Can Help
- Radon Gas Increases Risk Of Ovarian Cancer, Study Says
- Your Doctor Might Be Using The Wrong Test To Track Your Cholesterol, Study Says
- Losing Teeth May Lead to Weight Gain, Researchers Report
- Heart Risk Worse With Sleep Apnea That Varies Night-By-Night
- Lilly’s Jaypirca shows fixed-duration power in ‘ambitious’ phase 3 CLL trial win
- How To Make a High-Deductible Health Plan Work for You
- Pennsylvania Town Faces Fallout From Trump’s Environmental Rule Rollback
- CMS showcases first wave of digital health tools as questions about 'last mile' of adoption remain
- ViiV launches ‘Still Here’ campaign aimed at reminding young people about HIV
- Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
- How to Limit The Health Risks Posed by Polluted Air
- U.S. States Warm, But Not As Expected
- Rovner Recaps Medicaid Cuts’ Impact on Hospitals and Fields Caller Questions on Affordability
- UHS’ CEO-to-worker pay ratio over the past 5 years
- 5 new university programs tackling behavioral health workforce gaps
- Texas Children’s gets $5M gift for behavioral health services
- CMS proposes 2.4% hospital pay increase, nationwide mandatory model rollout
- Proposed CMS rule would set prior auth deadlines for drugs
- How Evernorth's new Delaware specialty pharmacy facility highlights a broader care coordination approach
- HHS, after legal setback, updates ACIP charter to put more emphasis on vaccine safety
- HHS, after legal setback, updates ACIP charter to put more emphasis on vaccine safety
- Costco Recalls Cookies Over Missing Nut Allergy Warning
- CDC Pauses Release of COVID Vaccine Effectiveness Study
- Demand Surge Leads to Shortages of Estrogen Patches
- Statement Regarding Staff No-Action Letter to Bank of England
- Op-ed: Administrative fragility is costing healthcare more than we think
- UPDATED: Replimune to reduce workforce following 'disappointing' second rejection for melanoma prospect
- Title X Funding Restored, but New Rules Raise Concerns
- Function Health acquires mobile healthcare platform Getlabs to provide members with at-home lab tests
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
- Blackstone and TPG Complete Acquisition of Hologic; Names New CEO
- Blackstone and TPG Complete Acquisition of Hologic; Names New CEO
- Endospan Receives FDA Approval for the NEXUS Aortic Arch Stent Graft System
- Endospan Receives FDA Approval for the NEXUS Aortic Arch Stent Graft System
- InVera Medical Receives FDA Clearance for Non-Thermal Chronic Venous Disease Device
- InVera Medical Receives FDA Clearance for Non-Thermal Chronic Venous Disease Device
- How CVS Caremark is using innovative technology to simplify the prior authorization process
- Starting material sourcing bottlenecks increase US drug shortage risks: report
- Novartis cuts 114 more jobs at New Jersey HQ as restructuring rolls on
- Charles River flows into Boston to help AHA bridge cardiovascular health divide
- Your Brain Cares If Your Plant-Based Diet Is Unhealthy, Researchers Report
- Your Neighborhood Might Help Make You Old Before Your Time
- Heavy 'Forever Chemical' Exposure Before Birth Increases Childhood Asthma Risk, Study Finds
- High-Tech Magnets Offer New Hope for Veterans Battling Combat PTSD
- Early Diagnosis Key To ADHD Child's Academic Success, Study Finds
- Study Reveals Who Americans Think Should Pay for Elder Care
- Envision hires ConcertAI, IQVIA alum Nick Jones as its med comms president
- The top 10 pharma R&D budgets of 2025
- Bial launches ‘Dialogues with Parkinson’s’ campaign aimed at identifying early symptoms
- Novartis pumps up community health footprint to tackle heart disease and cancer
- Abbott survey finds ‘information overload, confusion and cost’ affecting health choices in US
- FDA accuses Amneal, BioCorRx of producing ‘false and misleading’ drug promos
- Epic rolls out health alerts to flag rising rates of illness at the county level
- Hospital M&A roars back to life in Q1 2026; Operating performances fray in February
- Fierce Pharma Asia—Takeda-Denali split-up; Merck, Zhifei's revised deal; Shionogi's made-in-US plan
- Brain Scans Reveal How Psychedelics Change Perception
- Benefits leaders report increased operational, financial costs amid 'digital health vendor sprawl': Solera survey
- Vanda initiates study of motion sickness drug Nereus in GLP-1 users
- Judge Allows Abortion Pill, Mifepristone, To Continue Being Mailed for Now
- Bangladesh Measles Outbreak Kills 100+ Kids, Emergency Shots Begin
- Regulatory burdens continue to mount for physician practices
- Omnichannel Has an Access Problem. Compliant AI Fixes It.
Michigan Economic Development Corporation (MEDC) is also known as the slush fund for the Governor's cronies. MEDC sends out regular emails listing its various spending projects featured in the media.
Under the Snyder administration, daily emails featured 2-3 articles impacting healthcare.
Under the Whitmer administration, I see fewer than 1 per month. (Not watching as closely, I may miss a few.)
Yes, elections do make a difference.
Alerje in Detroit Partners with Mitsubishi to Revolutionize Allergy Care
Alerje Inc. in Detroit, which specializes in emergency medicine and food allergy management, and Mitsubishi Gas Chemical Co., a global leader in chemical and life sciences technologies, today announced a strategic partnership aimed at transforming allergy diagnosis and treatment on a global scale.Alerje Inc. in Detroit, which specializes in emergency medicine and food allergy management, and Mitsubishi Gas Chemical Co., a global leader in chemical and life sciences technologies, today announced a strategic partnership aimed at transforming allergy diagnosis and treatment on a global scale.
The synergy is expected to create a comprehensive, personalized allergy care solution that could significantly improve patient outcomes and quality of life. Food allergies affect 220 million people globally.
Key aspects of the partnership include:
- Joint efforts to bring advanced allergy diagnostic platforms to the United States market.
- Integration of food allergy technologies, aiming to create a holistic approach to personalized allergy care.
- This collaboration aligns with MGC’s strategic long-term plan, focusing on medical and food sectors.
“This partnership with MGC represents a significant milestone in our mission to improve the lives of millions affected by allergies,” says Javier Evelyn, founder and CEO of Alerje. “With our powers combined, we’re poised to deliver unprecedented advancements in allergy diagnosis and management.”
The partnership focuses on rethinking food allergy care. The work combines better testing with innovative therapies, aiming to change how people live with food allergies. The goal is to help people with food allergies live freely, not just cope with symptoms.
“We are excited about the potential of this collaboration with Alerje,” says Yoshinori Isahaya, director, managing executive officer at MGC. “Together, we aim to set new standards in allergy care, leveraging our combined technologies and expertise to address unmet needs in both the U.S. and Japanese markets.”
Alerje integrates emergency medicine with AI enabled digital health tools, and offers a remote patient monitoring platform backed by the National Science Foundation.
The platform gathers and processes vital information as well as predicts treatment outcomes, which enhances care strategies for allergists. Alerje’s internationally patented technology combines a low-cost life-saving epinephrine auto-injector with a smartphone case, ensuring patients have immediate access to medication, thus redefining adherence and emergency response.
Mitsubishi Gas Chemical is a leading global chemical company that develops and manufactures a wide range of products in the fields of basic chemicals, fine chemicals, and functional materials. With a strong focus on innovation and sustainability, MGC contributes to society through chemistry-based solutions.
For more information, visit alerje.com/.
Alerje has two primary products which can help patients with managing food allergies: the first being an epinephrine autoinjector that is attached to the patient's phone, the second being phone application to help track immunotherapy treatments.
In my experience as an EMT, patient outcomes for anaphylaxis have been better for those who received epinephrine earlier. If a patient is suffering from a highly severe allergy, having an autoinjector attached to their phone may be a good idea.
https://www.alerje.com/take-control
Introducing The Omniject™
Studies have shown* that when it comes to anaphylactic reactions, even minutes count. Get back to your life with less worry.
The patented smartphone-attached Omniject™ epinephrine auto-injector prioritizes storage, convenience, and safety.
Adhered to your phone case, Alerje's Ominiject™ will always be with you in case of emergency and will stay at the appropriate temperature for maximum epinephrine effectiveness.
Automatic alerts to the patient’s allergist, first responders, and support circle if a dose from the case is activated.
AIT by Alerje
Achieve life's goals beyond food allergies: Oral Immunotherapy (OIT) management to get you to the maintenance finish line.
Keeps you and your allergist connected, simplifying the Oral Immunotherapy process, plus treatment-specific resources.
Rewards and celebrates you for achieving OIT milestones and collects mental health data to share with your allergist, helping you work together to win OIT and achieve treatment goals.
Reminders to take your dose, alerting you and your allergist in case of missed doses through daily tracking.
There's no doubt the idea has merit.
The essential forgotten question in health policy today is whether government should do, or fund, or mandate A, B, or C. Remember limited government?
Law is force. Government acts only by taking our taxes. Too often, it uses them not to serve the general welfare, but according to its own priorities. (Politics, for example.)
The only way to avoid the special interest quagmire is to say No to such "public investing."
Legislators should shut down the governor's slush fund. The governor should send corporate beggars in a quick about-face to banks, friends, and other private lenders.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
Friends of MHF
Kirsten DeVries
Tom & Karen Nunheimer
Steve Ahonen
Ron & Faith Bosserman
Marlin & Kathy Klumpp
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
